Easy Access and Express Report Delivery Service
Table 155. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lipid Contract Manufacturing Product Picture Figure 5. Global Lipid Contract Manufacturing Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 6. Global Lipid Contract Manufacturing Market Share by Type: 2022 VS 2029 Figure 7. Liposomes Product Picture Figure 8. Lipid Nanoparticles Product Picture Figure 9. Global Lipid Contract Manufacturing Market Size by Application (2023-2029) & (US$ Million) Figure 10. Global Lipid Contract Manufacturing Market Share by Application: 2022 VS 2029 Figure 11. Preclinical Product Picture Figure 12. Clinical Product Picture Figure 13. Commercial Product Picture Figure 14. Global Lipid Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 15. Global Lipid Contract Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 16. Global Lipid Contract Manufacturing Market Share by Region: 2022 VS 2029 Figure 17. Global Lipid Contract Manufacturing Market Share by Players in 2022 Figure 18. Global Lipid Contract Manufacturing Players, Date of Enter into This Industry Figure 19. Global Top 5 and 10 Lipid Contract Manufacturing Players Market Share by Revenue in 2022 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 21. North America Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. North America Lipid Contract Manufacturing Market Share by Country (2018-2029) Figure 23. United States Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Canada Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Europe Lipid Contract Manufacturing Market Share by Country (2018-2029) Figure 27. Germany Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. France Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. U.K. Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Italy Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Russia Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Nordic Countries Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Asia-Pacific Lipid Contract Manufacturing Market Share by Country (2018-2029) Figure 35. China Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Japan Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. South Korea Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Southeast Asia Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. India Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Australia Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Latin America Lipid Contract Manufacturing Market Share by Country (2018-2029) Figure 43. Mexico Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Brazil Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Middle East & Africa Lipid Contract Manufacturing Market Share by Country (2018-2029) Figure 47. Turkey Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Saudi Arabia Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 49. UAE Lipid Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Precision NanoSystems Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 51. Evonik Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 52. Merck KGaA Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 53. Genevant Sciences Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 54. Exelead Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 55. Avanti Polar Lipids Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 56. Nippon Fine Chemical Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 57. Lipoid Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 58. Polymun Scientific Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 59. Corden Pharma Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Figure 60. Acuitas Therapeutics Revenue Growth Rate in Lipid Contract Manufacturing Business (2018-2023) Highlights The global Lipid Contract Manufacturing market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. North American market for Lipid Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Asia-Pacific market for Lipid Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. The major global companies of Lipid Contract Manufacturing include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid and Polymun Scientific, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue. The global market for Lipid Contract Manufacturing in Preclinical is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Liposomes, which accounted for % of the global market of Lipid Contract Manufacturing in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Lipid Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Contract Manufacturing. The Lipid Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lipid Contract Manufacturing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Lipid Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include: Precision NanoSystems Evonik Merck KGaA Genevant Sciences Exelead Avanti Polar Lipids Nippon Fine Chemical Lipoid Polymun Scientific Corden Pharma Acuitas Therapeutics Product Type Insights Global markets are presented by Lipid Contract Manufacturing type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Lipid Contract Manufacturing are procured by the companies. This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029). Lipid Contract Manufacturing segment by Type Liposomes Lipid Nanoparticles Application Insights This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029). This report also outlines the market trends of each segment and consumer behaviors impacting the Lipid Contract Manufacturing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Lipid Contract Manufacturing market. Lipid Contract Manufacturing Segment by Application Preclinical Clinical Commercial Regional Outlook This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029. North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Lipid Contract Manufacturing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. This report will help stakeholders to understand the global industry status and trends of Lipid Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This report stays updated with novel technology integration, features, and the latest developments in the market This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Lipid Contract Manufacturing industry. This report helps stakeholders to gain insights into which regions to target globally This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Contract Manufacturing. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Core Chapters Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Lipid Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report. Frequently Asked Questions What factors will challenge the Product Name market growth? Which end-use segment will expand at the fastest CAGR in the Product Name market? Which are the emerging players in the Product Name market? How concentrated is the Product Name market? Which factors are positively contributing to the Product Name market growth? Which are the novel product innovations in the Product Name market? Which product segment will emerge as the most lucrative in the Product Name market? Which factors are increasing the competition in the Product Name market? Which are the strategic measures taken by the Product Name industry players? Which region will witness inactive growth during the forecast period? What key trends are likely to emerge in the Product Name market in the coming years?
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Lipid Contract Manufacturing by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 Liposomes 1.2.3 Lipid Nanoparticles 2.3 Lipid Contract Manufacturing by Application 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) 2.3.2 Preclinical 2.3.3 Clinical 2.3.4 Commercial 2.4 Assumptions and Limitations 3 Lipid Contract Manufacturing Breakdown Data by Type 3.1 Global Lipid Contract Manufacturing Historic Market Size by Type (2018-2023) 3.2 Global Lipid Contract Manufacturing Forecasted Market Size by Type (2023-2028) 4 Lipid Contract Manufacturing Breakdown Data by Application 4.1 Global Lipid Contract Manufacturing Historic Market Size by Application (2018-2023) 4.2 Global Lipid Contract Manufacturing Forecasted Market Size by Application (2018-2023) 5 Global Growth Trends 5.1 Global Lipid Contract Manufacturing Market Perspective (2018-2029) 5.2 Global Lipid Contract Manufacturing Growth Trends by Region 5.2.1 Global Lipid Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Lipid Contract Manufacturing Historic Market Size by Region (2018-2023) 5.2.3 Lipid Contract Manufacturing Forecasted Market Size by Region (2024-2029) 5.3 Lipid Contract Manufacturing Market Dynamics 5.3.1 Lipid Contract Manufacturing Industry Trends 5.3.2 Lipid Contract Manufacturing Market Drivers 5.3.3 Lipid Contract Manufacturing Market Challenges 5.3.4 Lipid Contract Manufacturing Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Lipid Contract Manufacturing Players by Revenue 6.1.1 Global Top Lipid Contract Manufacturing Players by Revenue (2018-2023) 6.1.2 Global Lipid Contract Manufacturing Revenue Market Share by Players (2018-2023) 6.2 Global Lipid Contract Manufacturing Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Lipid Contract Manufacturing Head office and Area Served 6.4 Global Lipid Contract Manufacturing Players, Product Type & Application 6.5 Global Lipid Contract Manufacturing Players, Date of Enter into This Industry 6.6 Global Lipid Contract Manufacturing Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Lipid Contract Manufacturing Market Size (2018-2029) 7.2 North America Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Lipid Contract Manufacturing Market Size by Country (2018-2023) 7.4 North America Lipid Contract Manufacturing Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Lipid Contract Manufacturing Market Size (2018-2029) 8.2 Europe Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Lipid Contract Manufacturing Market Size by Country (2018-2023) 8.4 Europe Lipid Contract Manufacturing Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Lipid Contract Manufacturing Market Size (2018-2029) 9.2 Asia-Pacific Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Lipid Contract Manufacturing Market Size by Country (2018-2023) 9.4 Asia-Pacific Lipid Contract Manufacturing Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Lipid Contract Manufacturing Market Size (2018-2029) 10.2 Latin America Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Lipid Contract Manufacturing Market Size by Country (2018-2023) 10.4 Latin America Lipid Contract Manufacturing Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Lipid Contract Manufacturing Market Size (2018-2029) 11.2 Middle East & Africa Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2018-2023) 11.4 Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 Precision NanoSystems 11.1.1 Precision NanoSystems Company Detail 11.1.2 Precision NanoSystems Business Overview 11.1.3 Precision NanoSystems Lipid Contract Manufacturing Introduction 11.1.4 Precision NanoSystems Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.1.5 Precision NanoSystems Recent Development 11.2 Evonik 11.2.1 Evonik Company Detail 11.2.2 Evonik Business Overview 11.2.3 Evonik Lipid Contract Manufacturing Introduction 11.2.4 Evonik Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.2.5 Evonik Recent Development 11.3 Merck KGaA 11.3.1 Merck KGaA Company Detail 11.3.2 Merck KGaA Business Overview 11.3.3 Merck KGaA Lipid Contract Manufacturing Introduction 11.3.4 Merck KGaA Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.3.5 Merck KGaA Recent Development 11.4 Genevant Sciences 11.4.1 Genevant Sciences Company Detail 11.4.2 Genevant Sciences Business Overview 11.4.3 Genevant Sciences Lipid Contract Manufacturing Introduction 11.4.4 Genevant Sciences Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.4.5 Genevant Sciences Recent Development 11.5 Exelead 11.5.1 Exelead Company Detail 11.5.2 Exelead Business Overview 11.5.3 Exelead Lipid Contract Manufacturing Introduction 11.5.4 Exelead Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.5.5 Exelead Recent Development 11.6 Avanti Polar Lipids 11.6.1 Avanti Polar Lipids Company Detail 11.6.2 Avanti Polar Lipids Business Overview 11.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Introduction 11.6.4 Avanti Polar Lipids Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.6.5 Avanti Polar Lipids Recent Development 11.7 Nippon Fine Chemical 11.7.1 Nippon Fine Chemical Company Detail 11.7.2 Nippon Fine Chemical Business Overview 11.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Introduction 11.7.4 Nippon Fine Chemical Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.7.5 Nippon Fine Chemical Recent Development 11.8 Lipoid 11.8.1 Lipoid Company Detail 11.8.2 Lipoid Business Overview 11.8.3 Lipoid Lipid Contract Manufacturing Introduction 11.8.4 Lipoid Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.8.5 Lipoid Recent Development 11.9 Polymun Scientific 11.9.1 Polymun Scientific Company Detail 11.9.2 Polymun Scientific Business Overview 11.9.3 Polymun Scientific Lipid Contract Manufacturing Introduction 11.9.4 Polymun Scientific Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.9.5 Polymun Scientific Recent Development 11.10 Corden Pharma 11.10.1 Corden Pharma Company Detail 11.10.2 Corden Pharma Business Overview 11.10.3 Corden Pharma Lipid Contract Manufacturing Introduction 11.10.4 Corden Pharma Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.10.5 Corden Pharma Recent Development 11.11 Acuitas Therapeutics 11.11.1 Acuitas Therapeutics Company Detail 11.11.2 Acuitas Therapeutics Business Overview 11.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Introduction 11.11.4 Acuitas Therapeutics Revenue in Lipid Contract Manufacturing Business (2017-2022) 11.11.5 Acuitas Therapeutics Recent Development 13 Report Conclusion 14 Disclaimer